Mandate

Vinge represents Gambro in the sale of Gambro Healthcare

May 10, 2007

Vinge is representing Gambro in the sale of Gambro Healthcare to Bridgepoint. The sale of Gambro Healthcare was a part of the plan that was implemented when Investor and EQT acquired Gambro in June 2006. The sale requires the approval of the EU Commission before it can be concluded.
 
The partner in charge is Fredrik von Baumgarten, who is assisted by associates Tuula Tallavaara, Ulrich Ziche, Marion Ehman and Martin Hall. For financial matters, Gambro is represented by Fabian Ekeblad, together with Ann Bokinge and Hanna Fanning.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025